Evaluation of Serum Protein Binding by Using in Vitro Pharmacological Activity for the Effective Pharmacokinetics Profiling in Drug Discovery
スポンサーリンク
概要
- 論文の詳細を見る
The establishment of a new index for the profile of serum protein binding was analyzed theoretically. The in vitro pharmacological activity ratio of the inhibition constant in the absence of serum protein to that in its presence (activity ratio), which represents the extent of specific binding to serum protein, was suggested as the new index. To clarify the usefulness of the activity ratio, theoretical analysis by the activity ratio for 3% human serum albumin was examined in comparison with conventional methods of equilibrium dialysis. In-house very late antigen-4 antagonists were used as model compounds, whose pharmacokinetics were strongly influenced by serum protein binding. Although the theoretical and actual unbound fractions were similar, the latter tended to be slightly lower than the former. This small difference was considered to correspond to nonspecific binding. These results suggested that the specific and nonspecific binding could be discriminated by comparing the activity ratio data with those of conventional methods. Moreover, the activity ratio was suggested to be useful in profiling the influence of protein binding on pharmacokinetics. In conclusion, it was considered that the activity ratio could avoid the risk of misleading interpretation by nonspecific binding in pharmacokinetics/pharmacological activity. Moreover, the activity ratio was considered to be valuable as one of the useful parameters in pharmacokinetics profiling and as a tool of rational drug design for drug discovery.
著者
-
Kawai Yukinori
Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd.
-
Fujii Yoshimine
Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd.
-
Akimoto Katsuya
Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd.
-
Takahashi Masayuki
Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd.
-
Takahashi Masayuki
Drug Delivery Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
Akimoto Katsuya
Drug Metabolism & Pharmacokinetics Res. Laboratories Daiichi Sankyo Co. Ltd.
-
Fujii Yoshimine
Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd.
関連論文
- Investigation of the Intestinal Permeability and First-Pass Metabolism of Drugs in Cynomolgus Monkeys Using Single-Pass Intestinal Perfusion
- Evaluation of Serum Protein Binding by Using in Vitro Pharmacological Activity for the Effective Pharmacokinetics Profiling in Drug Discovery
- Photochemical Behavior of Sitafloxacin, Fluoroquinolone Antibiotic, in an Aqueous Solution
- Characteristics of Gastrointestinal Absorption of DX-9065a, a New Synthetic Anticoagulant
- 製剤研究におけるin silico研究の有用性と問題点
- Effect of Vehicles on Percutaneous Absorption of Bucladesine (Dibutyryl Cyclic AMP) in Normal and Damaged Rat Skin
- 11 ブクラデシン外用散剤の基礎的検討
- Photodecarboxylation of DX-9065a, a New Factor Xa Inhibitor, in Aqueous Solution
- Interaction of Quinolones with Metal Cations in Aqueous Solution
- A Novel Redox Reaction of Ebselen with Alcohol in Basic Solution
- A Risk Assessment of Human Ether-a-Go-Go-Related Gene Potassium Channel Inhibition by Using Lipophilicity and Basicity for Drug Discovery